CMMB
Price
$1.42
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
5 days until earnings call
MDGL
Price
$259.34
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
115 days until earnings call
Ad is loading...

CMMB vs MDGL

Header iconCMMB vs MDGL Comparison
Open Charts CMMB vs MDGLBanner chart's image
Chemomab Therapeutics
Price$1.42
Change-$0.00 (-0.00%)
Volume$22.78K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$259.34
Change-$0.00 (-0.00%)
Volume$117.37K
CapitalizationN/A
View a ticker or compare two or three
CMMB vs MDGL Comparison Chart
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CMMB vs. MDGL commentary
Nov 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a StrongSell and MDGL is a Hold.

COMPARISON
Comparison
Nov 03, 2024
Stock price -- (CMMB: $1.42 vs. MDGL: $259.34)
Brand notoriety: CMMB and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 11% vs. MDGL: 41%
Market capitalization -- CMMB: $26.02M vs. MDGL: $6.97B
CMMB [@Biotechnology] is valued at $26.02M. MDGL’s [@Biotechnology] market capitalization is $6.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $494.31B to $0. The average market capitalization across the [@Biotechnology] industry is $2.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • CMMB’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both CMMB and MDGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 5 TA indicator(s) are bullish while MDGL’s TA Score has 4 bullish TA indicator(s).

  • CMMB’s TA Score: 5 bullish, 5 bearish.
  • MDGL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CMMB is a better buy in the short-term than MDGL.

Price Growth

CMMB (@Biotechnology) experienced а -1.39% price change this week, while MDGL (@Biotechnology) price change was +23.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

CMMB is expected to report earnings on Mar 06, 2025.

MDGL is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.97B) has a higher market cap than CMMB($26M). CMMB YTD gains are higher at: 178.431 vs. MDGL (12.084). CMMB has higher annual earnings (EBITDA): -15.97M vs. MDGL (-494.77M). MDGL has more cash in the bank: 1.06B vs. CMMB (12.7M). CMMB has less debt than MDGL: CMMB (360K) vs MDGL (118M). MDGL has higher revenues than CMMB: MDGL (14.6M) vs CMMB (0).
CMMBMDGLCMMB / MDGL
Capitalization26M6.97B0%
EBITDA-15.97M-494.77M3%
Gain YTD178.43112.0841,477%
P/E RatioN/AN/A-
Revenue014.6M-
Total Cash12.7M1.06B1%
Total Debt360K118M0%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
35
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMMBMDGL
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 17 days ago
88%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTR48.360.68
+1.43%
Nutrien Ltd
CRCT6.58N/A
N/A
Cricut
MGNX3.66N/A
N/A
MacroGenics
SONM3.32-0.04
-1.04%
Sonim Technologies Inc.
MAIN50.67-0.67
-1.31%
Main Street Capital Corp

CMMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
N/A
AXON - CMMB
37%
Loosely correlated
N/A
SPRB - CMMB
36%
Loosely correlated
+3.20%
DSGN - CMMB
30%
Poorly correlated
-0.76%
MDGL - CMMB
29%
Poorly correlated
N/A
CNTX - CMMB
28%
Poorly correlated
+4.13%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with VXRT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then VXRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
N/A
VXRT - MDGL
61%
Loosely correlated
N/A
ALXO - MDGL
56%
Loosely correlated
N/A
REPL - MDGL
55%
Loosely correlated
N/A
ZNTL - MDGL
51%
Loosely correlated
+21.61%
CGEM - MDGL
50%
Loosely correlated
N/A
More